Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.
D000818:Animals; D001854:Bone Marrow Cells; D001855:Bone Marrow Diseases / Q000628:therapy; D016026:Bone Marrow Transplantation; D002471:Cell Transformation, Neoplastic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004285:Dogs; D005260:Female; D006087:Graft vs Host Reaction; D006648:Histocompatibility; D006649:Histocompatibility Antigens / Q000032:analysis; D006650:Histocompatibility Testing; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011828:Radiation Chimera; D012737:Sex Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous
D006649:Histocompatibility Antigens; D003520:Cyclophosphamide; D008727:Methotrexate